GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » NextGen Biomed Ltd (XTAE:NXGN) » Definitions » 1-Year ROIIC %

NextGen Biomed (XTAE:NXGN) 1-Year ROIIC % : 15.01% (As of Jun. 2023)


View and export this data going back to 2000. Start your Free Trial

What is NextGen Biomed 1-Year ROIIC %?

1-Year Return on Invested Incremental Capital (1-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 1-year. NextGen Biomed's 1-Year ROIIC % for the quarter that ended in Jun. 2023 was 15.01%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for NextGen Biomed's 1-Year ROIIC % or its related term are showing as below:

XTAE:NXGN's 1-Year ROIIC % is ranked better than
65.51% of 835 companies
in the Medical Devices & Instruments industry
Industry Median: -2.25 vs XTAE:NXGN: 15.01

NextGen Biomed 1-Year ROIIC % Historical Data

The historical data trend for NextGen Biomed's 1-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NextGen Biomed 1-Year ROIIC % Chart

NextGen Biomed Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
1-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only -2,515.38 -57.69 -3.66 -16.71 52.39

NextGen Biomed Semi-Annual Data
Dec13 Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
1-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -16.71 -30.16 52.39 15.01

Competitive Comparison of NextGen Biomed's 1-Year ROIIC %

For the Medical Instruments & Supplies subindustry, NextGen Biomed's 1-Year ROIIC %, along with its competitors' market caps and 1-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NextGen Biomed's 1-Year ROIIC % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, NextGen Biomed's 1-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where NextGen Biomed's 1-Year ROIIC % falls into.



NextGen Biomed 1-Year ROIIC % Calculation

NextGen Biomed's 1-Year ROIIC % for the quarter that ended in Jun. 2023 is calculated as:

1-Year ROIIC %=1-Year Incremental Net Operating Profit After Taxes (NOPAT)**/1-Year Incremental Invested Capital
=( -3.989 (Jun. 2023) - -3.198 (Jun. 2022) )/( 10.154 (Jun. 2023) - 15.425 (Jun. 2022) )
=-0.791/-5.271
=15.01%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** TTM data of NOPAT and Invested Capital was used to calculate 1-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


NextGen Biomed  (XTAE:NXGN) 1-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


NextGen Biomed 1-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of NextGen Biomed's 1-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


NextGen Biomed (XTAE:NXGN) Business Description

Traded in Other Exchanges
N/A
Address
Azrieli Center, Round Tower 22nd Floor, Tel Aviv, ISR, 6701101
NextGen Biomed Ltd is pharmaceutical company. It manufactures medical instruments. Its products include pain-free auto-injectors, lancet devices and personal use pain alleviators. It develops and markets medical equipments. Its product line include DPS-101, which is used for treatment for psoriasis. Its other product line include DPS-101 phase II/III is in clinical trial.